Orlistat
A Study of Xenical (Orlistat) in Overweight and Obese Adolescents
Empros Pharma AB · Phase 3 · Completed · Enrollment 60
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| 1 | n/r | n/r | n/r | n/r |
| 2 | n/r | n/r | n/r | n/r |
Not shown
- 1: endpoint not reported
- 2: endpoint not reported